Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Equity Average (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Equity Average readings, the most recent being $18.4 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 213.5% to $18.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.4 million, a 213.5% increase, with the full-year FY2025 number at $8.2 million, up 430.1% from a year prior.
  • Equity Average hit $18.4 million in Q4 2025 for Lucid Diagnostics, up from $16.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $50.6 million in Q1 2022 to a low of -$22.0 million in Q3 2021.
  • Median Equity Average over the past 5 years was $12.5 million (2024), compared with a mean of $11.7 million.
  • Biggest five-year swings in Equity Average: soared 4687.35% in 2024 and later crashed 99.85% in 2025.
  • Lucid Diagnostics' Equity Average stood at $15.3 million in 2021, then skyrocketed by 65.27% to $25.3 million in 2022, then plummeted by 99.52% to $122500.0 in 2023, then soared by 4687.35% to $5.9 million in 2024, then surged by 213.5% to $18.4 million in 2025.
  • The last three reported values for Equity Average were $18.4 million (Q4 2025), $16.8 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.